Financials data is unavailable for this security.
View more
Year on year AtriCure Inc grew revenues 20.84% from 330.38m to 399.25m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -46.47m to -30.44m.
| Gross margin | 74.84% |
|---|---|
| Net profit margin | -9.33% |
| Operating margin | -8.42% |
| Return on assets | -6.73% |
|---|---|
| Return on equity | -8.68% |
| Return on investment | -7.58% |
More ▼
Cash flow in USDView more
In 2023, AtriCure Inc increased its cash reserves by 45.11%, or 26.21m. Cash Flow from Investing totalled 21.82m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 4.48m in cash from operations while cash used for financing totalled 32.00k.
| Cash flow per share | -0.4902 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 9.49 |
|---|---|
| Tangible book value per share | 3.43 |
More ▼
Balance sheet in USDView more
| Current ratio | 4.13 |
|---|---|
| Quick ratio | 2.93 |
| Total debt/total equity | 0.1363 |
|---|---|
| Total debt/total capital | 0.12 |
More ▼
